Espen Stang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Espen Stang has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Finn O. Levy
MSD Cardiovascular Research Center, Rikshospitalet University Hospital and Department of Pharmacology, University of Oslo, N-0316 Oslo, Norway
1 shared publicationFrøydis D. Blystad
Institute of Pathology, University of Oslo, Rikshospitalet University Hospital, N-0027 Oslo, Norway
1 shared publicationInger H. Madshus
Institute of Pathology, University of Oslo, Rikshospitalet University Hospital, N-0027 Oslo, Norway
1 shared publicationInger Helene Madshus
1 shared publicationLene E. Johannessen
1 shared publicationSigrun L. Knardal
1 shared publication
Latest Publications
- Open Access
- 15 March 2002
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 115 (6) , 1331-1340
Cholesterol is important in control of EGF receptor kinase activity but EGF receptors are not concentrated in caveolae
We have investigated the localization and function of the epidermal growth factor receptor (EGFR) in normal cells, in cholesterol-depleted cells and in cholesterol enriched cells. Using immunoelectron microscopy we find that the EGFR is randomly distributed at the plasma membrane and not enriched in caveolae. Binding of EGF at 4°C does not change the localization of EGFR,and by immunoelectron microscopy we find that only small amounts of bound EGF localize to caveolae. However, upon patching of lipid rafts, we find that a significant amount of the EGFR is localized within rafts. Depletion of the plasma membrane cholesterol causes increased binding of EGF, increased dimerization of the EGFR, and hyperphosphorylation of the EGFR. Addition of cholesterol was found to reduce EGF binding and reduce EGF-induced EGFR activation. Our results suggest that the plasma membrane cholesterol content directly controls EGFR activation.
- 15 March 2002
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 115 (6) , 1331-1340
Open AccessCholesterol is important in control of EGF receptor kinase activity but EGF receptors are not concentrated in caveolae
We have investigated the localization and function of the epidermal growth factor receptor (EGFR) in normal cells, in cholesterol-depleted cells and in cholesterol enriched cells. Using immunoelectron microscopy we find that the EGFR is randomly distributed at the plasma membrane and not enriched in caveolae. Binding of EGF at 4°C does not change the localization of EGFR,and by immunoelectron microscopy we find that only small amounts of bound EGF localize to caveolae. However, upon patching of lipid rafts, we find that a significant amount of the EGFR is localized within rafts. Depletion of the plasma membrane cholesterol causes increased binding of EGF, increased dimerization of the EGFR, and hyperphosphorylation of the EGFR. Addition of cholesterol was found to reduce EGF binding and reduce EGF-induced EGFR activation. Our results suggest that the plasma membrane cholesterol content directly controls EGFR activation.
- Open Access
- 1 May 2000
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 275 (18) , 13940-13947
Polyubiquitination of the Epidermal Growth Factor Receptor Occurs at the Plasma Membrane upon Ligand-induced Activation
- 1 May 2000
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 275 (18) , 13940-13947
Open AccessPolyubiquitination of the Epidermal Growth Factor Receptor Occurs at the Plasma Membrane upon Ligand-induced Activation